COLL Q4 2019 Earnings — Collegium Pharmaceutical, Inc. Revenue & Financial Results | Market Cap Arena

COLLCollegium Pharmaceutical, Inc.

$1B

Q4 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$74M+1.1% YoY

Gross Profit

$25M33.8% margin

Operating Income

-$2M-3.2% margin

Net Income

-$2M-3.0% margin

EPS (Diluted)

$-0.07

QoQ Revenue Growth

+1.7%

Cash Flow

Operating Cash Flow

$16M

Free Cash Flow

$15M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$306M

Total Liabilities

$219M

Stockholders' Equity

$87M

Cash & Equivalents

$170M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$74M	$73M	+1.1%
Gross Profit	$25M	$44M	-42.5%
Operating Income	-$2M	$11M	-121.6%
Net Income	-$2M	$9M	-124.2%